HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 90/2/415    most recent ajcn.2009.27680v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Bouwens, M. Articles by Afman, L. A PubMed PubMed Citation Articles by Bouwens, M. Articles by Afman, L. A Agricola Articles by Bouwens, M. Articles by Afman, L. A

Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells^1,2,3

¹ From the Nutrition, Metabolism and Genomics Group, Division of Human Nutrition, Wageningen University, Wageningen, Netherlands (MB, ND, MGB, MM, and LAA); the Nutrition and Health Group, Division of Human Nutrition, Wageningen University, Wageningen, Netherlands (OvdR, LCPGMdG, and JMG); and Nutrigenomics Consortium, Top Institute Food & Nutrition, Wageningen, Netherlands (MGB, MM, and LAA).

² Supported by the Dutch Dairy Association, Zoetermeer, Netherlands; the Nutrigenomics consortium of TI Food and Nutrition, Wageningen, Netherlands; the European Nutrigenomics Organisation; and the Netherlands Organization for Health Research and Development (ZonMw, grant number 6100.0004), The Hague, Netherlands.

³ Address correspondence to LA Afman, Nutrition, Metabolism and Genomics Group, Division of Human Nutrition, Wageningen University, Bomenweg 2, 6703 HD Wageningen, Netherlands. E-mail: lydia.afman{at}wur.nl.

Background: Polyunsaturated fatty acids can have beneficial effects on human immune cells, such as peripheral blood mononuclear cells (PBMCs). However, the mechanisms of action of polyunsaturated fatty acids on immune cells are still largely unknown.

Objective: The objective was to examine the effects of supplementation with the polyunsaturated fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on whole-genome PBMC gene expression profiles, in healthy Dutch elderly subjects participating in a double-blind trial, by using whole-genome transcriptomics analysis.

Design: The subjects were randomly allocated to 1 of 3 groups: 1) consumption of 1.8 g EPA+DHA/d (n = 36), 2) consumption of 0.4 g EPA+DHA/d (n = 37), or 3) consumption of 4.0 g high–oleic acid sunflower oil (HOSF)/d (n = 38). All supplements were given in capsules. Before and after 26 wk of intervention, blood samples were collected. Microarray analysis was performed on PBMC RNA from 23 subjects who received 1.8 g EPA+DHA/d and 25 subjects who received HOSF capsules. Quantitative real-time polymerase chain reaction was performed in all 111 subjects.

Results: A high EPA+DHA intake changed the expression of 1040 genes, whereas HOSF intake changed the expression of only 298 genes. EPA+DHA intake resulted in a decreased expression of genes involved in inflammatory- and atherogenic-related pathways, such as nuclear transcription factor B signaling, eicosanoid synthesis, scavenger receptor activity, adipogenesis, and hypoxia signaling.

Conclusion: These results are the first to show that intake of EPA+DHA for 26 wk can alter the gene expression profiles of PBMCs to a more antiinflammatory and antiatherogenic status. This trial was registered at clinicaltrials.gov as NCT00124852.